Hoppa till innehåll

Ortivus strengthens liquidity to accelerate the company’s growth strategy

2026-03-31 08:25

Ortivus is enabling increased investment in its growth strategy by further strengthening its financial position with an additional loan of SEK 5 million, following the full utilisation of the SEK 20 million credit facility with Ponderus Invest AB.

The focus is on further developing existing markets, with the launch of MobiMed 5 in Sweden as a key element, as well as expanding the company’s global operations and establishing a presence in new markets. The growth strategy entails higher costs for ongoing procurement processes alongside increased working capital tied up in inventory and accounts receivable. The strengthened cash position supports the creation of a more stable and scalable business, well-positioned for continued expansion and long-term value creation.

Get in touch

Empower your team with smarter solutions

Discover why leading healthcare organisations are choosing Ortivus.

Get contacted

Fill in the form and one of our sales representatives will contact you as soon as possible.

Required